ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway
Abstract Background Clear cell renal cell carcinoma (ccRCC) is a major worldwide health problem due to its high prevalence and mortality rate. A disintegrin and metalloproteinase 12 (ADAM12) is aberrantly expressed in various cancers and plays an important role in tumor progression. However, its exp...
Main Authors: | Jinming Xu, Yan Wang, Jiahao Jiang, Cong Yin, Bentao Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-03913-1 |
Similar Items
-
A Bispecific Inhibitor of the EGFR/ADAM17 Axis Decreases Cell Proliferation and Migration of EGFR-Dependent Cancer Cells
by: Abel Soto-Gamez, et al.
Published: (2020-02-01) -
NCOA7 Regulates Growth and Metastasis of Clear Cell Renal Cell Carcinoma via MAPK/ERK Signaling Pathway
by: Jiayu Guo, et al.
Published: (2023-07-01) -
Regulation of Fibrotic Processes in the Liver by ADAM Proteases
by: Dirk Schmidt-Arras, et al.
Published: (2019-10-01) -
Long non-coding RNA LINC00565 regulates ADAM19 expression through sponging microRNA-532-3p, thereby facilitating clear cell renal cell carcinoma progression
by: Bin Meng, et al.
Published: (2023-01-01) -
Construction of EMT related prognostic signature for kidney renal clear cell carcinoma, through integrating bulk and single-cell gene expression profiles
by: Qi Huang, et al.
Published: (2023-11-01)